Neurocrine Bioscience buy Morgan Stanley
Start price
12.07.24
/
50%
€136.55
Target price
12.07.25
€155.89
Performance (%)
-0.04%
Price
23.08.24
€136.50
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley for Neurocrine Bioscience is nearly unchanged. This prediction currently runs until 12.07.25. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | 3.842% | 3.842% |
iShares Core DAX® | 1.665% | 0.362% |
iShares Nasdaq 100 | -0.475% | -3.195% |
iShares Nikkei 225® | 2.620% | 1.174% |
iShares S&P 500 | -0.091% | -1.597% |
Comments by Morgan_Stanley for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Morgan Stanley from $160.00 to $170.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€124.65
12.06.24
12.06.24
€147.54
12.06.25
12.06.25
9.51%
23.08.24
23.08.24